Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11634508 Peptide conjugates of cytotoxins as therapeutics

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Robert John Maguire0

Daniel Richard Marshall0

Johanna Marie Csengery0

Robert A. Volkmann0

Date of Patent

April 25, 2023

0

Patent Application Number

169250940

Date Filed

July 9, 2020

0

Patent Citations

US Patent 10383878 Anti-HER3 antibody-drug conjugate

0

US Patent 10413615 Process for preparing cell-binding agent-cytotoxic agent conjugates

0

US Patent 10435432 Preparation of maytansinoid antibody conjugates by a one-step process

0

US Patent 10695396 Malignant tumor target peptide

0

US Patent 10844135 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said

0

US Patent 10729782 Antibody-drug conjugate produced by binding through linker having hydrophilic structure

0

US Patent 10933069 Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues

0

US Patent 10064855 Composite nanoparticles and uses thereof

0

...

Patent Primary Examiner

Noble E Jarrell

0

CPC Code

0

0

0

The present invention relates to peptide conjugates of cytotoxins such as topoisomerase I inhibitors which are useful for the treatment of diseases such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11634508 Peptide conjugates of cytotoxins as therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool